Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
21 hedge funds and large institutions have $1.56M invested in Biocept, Inc. in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 20 → 21 (+1)
8.66% less ownership
Funds ownership: 16.96% → 8.3% (-8.7%)
62% less capital invested
Capital invested by funds: $4.14M → $1.56M (-$2.58M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$417K |
| 2 |
Barclays
London,
United Kingdom
|
+$109K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$71.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$30K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$22.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$552K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$364K |
| 3 |
VF
Virtu Financial
New York
|
-$80K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$8K |
BIOC Hedge Fund Activity: Q1 2018 in Review
21 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2018, worth a combined $1.56M — down 62% from $4.14M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BIOC positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Perkins Capital Management, opening a new position worth an estimated $417K. The largest seller was Susquehanna International Group, cutting an estimated $552K.
- 21 institutional investors held Biocept, Inc. (BIOC) as of Q1 2018, up from 20 in Q4 2017.
- Funds reported $1.56M of Biocept, Inc. stock for Q1 2018, down 62% quarter-over-quarter.
- 3 funds opened new Biocept, Inc. positions in Q1 2018 and 2 closed out, a net change of +1 holder.
- The largest Biocept, Inc. buyer in Q1 2018 was Perkins Capital Management, an estimated $417K added.
- The largest Biocept, Inc. seller in Q1 2018 was Susquehanna International Group, an estimated $552K sold.
Based on aggregated 13F filings for Q1 2018.